Literature DB >> 12429237

Transplantation of M213-2O cells with enhanced GAD67 expression into the inferior colliculus alters audiogenic seizures.

Karen C Ross1, Barbara C Waldman, Concepcion Conejero-Goldberg, William Freed, James R Coleman.   

Abstract

The purpose of the present study was to examine the effects of GABA-producing cell transplants on audiogenic seizures (AGS). The M213-2O cell line was derived from fetal rat striatum and has GABAergic properties. This cell line was further modified to express human GAD(67) and produce elevated levels of GABA. The present study compares the effects of parent M213-2O cell transplants with those of GAD(67)-modified M213-2O cells in AGS-prone Long-Evans rats. Two weeks following implantation of engineered cells, latency to AGS-typical wild running was increased compared to nonimplanted subjects. Survival of the transplanted cells was confirmed by immunochemical labeling of GAD(67) and Epstein-Barr virus nuclear antigen. These findings support the use of GABA-producing cell lines to modify seizure activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429237     DOI: 10.1006/exnr.2002.7987

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

Review 1.  Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit.

Authors:  Steven C Schachter; John Guttag; Steven J Schiff; Donald L Schomer
Journal:  Epilepsy Behav       Date:  2009-09       Impact factor: 2.937

2.  Intranigral transplants of a GABAergic cell line produce long-term alleviation of established motor seizures.

Authors:  Claudia G Castillo; Soledad Mendoza-Trejo; Manuel B Aguilar; William J Freed; Magda Giordano
Journal:  Behav Brain Res       Date:  2008-05-04       Impact factor: 3.332

3.  Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures.

Authors:  Marc W Nolte; Wolfgang Löscher; Christiane Herden; William J Freed; Manuela Gernert
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.